Clive Meanwell

Clive A. Meanwell was the founder of The Medicines Co., founded in 1996, where the title held was Chief Innovation Officer & Director in 2020.
Dr. Meanwell is the founder of Population Health Partners LLC, founded in 2020, holding the title of Chairman & Managing Partner since 2020.
Dr. Meanwell is the founder of Population Health Investment Co., Inc., founded in 2020, holding the title of Chief Executive Officer & Director since 2020.
Dr. Meanwell was the founder of Metsera, Inc., founded in 2022, where the title held was Executive Chairman from 2024 to 2025.
Dr. Meanwell is also the founder of Corsera Health, Inc...
Dr. Meanwell is currently Chief Executive Officer & Director at Annovation BioPharma, Inc. Dr. Meanwell is a Director at Saama Technologies, Inc. since 2021.
Dr. Meanwell is a Director at Pharmaceutical Research & Manufacturers of America.
Dr. Meanwell is an Independent Director at Fractyl Health, Inc. since 2021.
Dr. Meanwell is a Director at Hugo Health, Inc. since 2021.
Dr. Meanwell is a Director at Comanche Biopharma Corp.
since 2021.
Dr. Meanwell is a Member at Biotechnology Innovation Organization.
Former positions include Chief Executive Officer at Rempex Pharmaceuticals, Inc. Vice Chairman at BB Biotech AG from 2011 to 2026.
Senior VP & Director-Pharmaceutical Division at Roche Holding AG from 1987 to 1996.
Director at Endo Health Solutions, Inc. from 2005 to 2010.
Managing Director & Partner at MPM BioImpact LLC from 1995 to 1996.
Independent Director at EQRx, Inc. from 2020 to 2023.
Director at Invivyd, Inc. from 2022 to 2024.
President at Targanta Therapeutics Corp.
Senior Vice President at Hoffmann-La Roche, Inc. from 1992 to 1995.
Education includes a doctorate from the University of Birmingham.